We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




SpaceLabs Forms Patient Monitoring Firm

By HospiMedica staff writers
Posted on 11 Jan 2006
A new consolidated patient-monitoring company, Spacelabs Healthcare (Issaquah, WA, USA), has been formed by combining Spacelabs Medical, a subsidiary of OSI Systems (Hawthorne, CA, USA), and two of OSI's businesses: Blease Medical Equipment (Chesham, UK) and Dolphin Medical (Hawthorne, CA, USA). More...


The new firm has several divisions, based on the products of the firms involved. All the firms will continue to operate under their own names. Dolphin Medical is a global leader in patient monitoring, whose products include the UltraviewSL family of patient monitors, digital telemetry systems, and connectivity solutions, such as Intesys Clinical Suite (ICS), Flexport interfaces, and WinDNA, designed to make real-time patient information quickly and easily available to clinicians. Blease, an international provider of anesthesia delivery systems, also offers ventilation systems, including the Focus and Sirius families of products, and supplies original equipment manufacture (OEM) products and components to the anesthesia industry.

The new Medical Solutions division includes Dolphin Medical's pulse oximetry, Spacelabs' Medical Data, recognized as a leader in ambulatory blood pressure (ABP) studies, and the Osteometer MediTech of OSI. The latter develops and manufactures bone densitometers, a potential growth area for the company as the global population ages. The new division also provides strong support for cardiac monitoring and research.

Additionally, Spacelabs Medical Data will continue to provide electrocardiogram (ECG) laboratory services to pharmaceutical companies undertaking clinical trials, whereby patient ECG data are recorded, analyzed, tabulated, and interpreted

According to Joe Davin, president of global sales and marketing for Spacelabs Healthcare, there are a number of benefits resulting from the formation of the new company. "Customers are the real winners in this consolidation. By strengthening the linkages among our healthcare businesses, we will give our customers a broader range of products and solutions coordinated across care areas, particularly in perioperative and critical care.”





Related Links:
Spacelabs Healthcare

Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Heavy-Duty Wheelchair Scale
6495 Stationary
Exam Table
PF400
PACS Workstation
PaxeraView PRO
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.